Exploring the origins of neurodevelopmental proteasomopathies associated with cardiac malformations: are neural crest cells central to certain pathological mechanisms?

cardiac malformations compensatory pathways craniofacial anomalies neural crest cells neurodevelopmental proteasomopathies protein homeostasis

Journal

Frontiers in cell and developmental biology
ISSN: 2296-634X
Titre abrégé: Front Cell Dev Biol
Pays: Switzerland
ID NLM: 101630250

Informations de publication

Date de publication:
2024
Historique:
received: 15 01 2024
accepted: 05 06 2024
medline: 29 7 2024
pubmed: 29 7 2024
entrez: 29 7 2024
Statut: epublish

Résumé

Neurodevelopmental proteasomopathies constitute a recently defined class of rare Mendelian disorders, arising from genomic alterations in proteasome-related genes. These alterations result in the dysfunction of proteasomes, which are multi-subunit protein complexes essential for maintaining cellular protein homeostasis. The clinical phenotype of these diseases manifests as a syndromic association involving impaired neural development and multisystem abnormalities, notably craniofacial anomalies and malformations of the cardiac outflow tract (OFT). These observations suggest that proteasome loss-of-function variants primarily affect specific embryonic cell types which serve as origins for both craniofacial structures and the conotruncal portion of the heart. In this hypothesis article, we propose that neural crest cells (NCCs), a highly multipotent cell population, which generates craniofacial skeleton, mesenchyme as well as the OFT of the heart, in addition to many other derivatives, would exhibit a distinctive vulnerability to protein homeostasis perturbations. Herein, we introduce the diverse cellular compensatory pathways activated in response to protein homeostasis disruption and explore their potential implications for NCC physiology. Altogether, the paper advocates for investigating proteasome biology within NCCs and their early cranial and cardiac derivatives, offering a rationale for future exploration and laying the initial groundwork for therapeutic considerations.

Identifiants

pubmed: 39071803
doi: 10.3389/fcell.2024.1370905
pii: 1370905
pmc: PMC11272537
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1370905

Informations de copyright

Copyright © 2024 Vignard, Baruteau, Toutain, Mercier, Isidor, Redon, Schott, Küry, Bézieau, Monsoro-Burq and Ebstein.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.

Auteurs

Virginie Vignard (V)

Nantes Université, CHU Nantes, CNRS, INSERM, l'institut du thorax, Nantes, France.

Alban-Elouen Baruteau (AE)

Nantes Université, CHU Nantes, CNRS, INSERM, l'institut du thorax, Nantes, France.
CHU Nantes, Department of Pediatric Cardiology and Pediatric Cardiac Surgery, FHU PRECICARE, Nantes Université, Nantes, France.
Nantes Université, CHU Nantes, INSERM, CIC FEA 1413, Nantes, France.

Bérénice Toutain (B)

Nantes Université, CNRS, INSERM, l'institut du thorax, Nantes, France.

Sandra Mercier (S)

Nantes Université, CHU Nantes, CNRS, INSERM, l'institut du thorax, Nantes, France.
CHU Nantes, Service de Génétique Médicale, Nantes Université, Nantes, France.

Bertrand Isidor (B)

Nantes Université, CHU Nantes, CNRS, INSERM, l'institut du thorax, Nantes, France.
CHU Nantes, Service de Génétique Médicale, Nantes Université, Nantes, France.

Richard Redon (R)

Nantes Université, CNRS, INSERM, l'institut du thorax, Nantes, France.

Jean-Jacques Schott (JJ)

Nantes Université, CNRS, INSERM, l'institut du thorax, Nantes, France.

Sébastien Küry (S)

Nantes Université, CHU Nantes, CNRS, INSERM, l'institut du thorax, Nantes, France.
CHU Nantes, Service de Génétique Médicale, Nantes Université, Nantes, France.

Stéphane Bézieau (S)

Nantes Université, CHU Nantes, CNRS, INSERM, l'institut du thorax, Nantes, France.
CHU Nantes, Service de Génétique Médicale, Nantes Université, Nantes, France.

Anne H Monsoro-Burq (AH)

Faculté des Sciences d'Orsay, CNRS, UMR 3347, INSERM, Université Paris-Saclay, Orsay, France.
Institut Curie, PSL Research University, CNRS, UMR 3347, INSERM, Orsay, France.
Institut Universitaire de France, Paris, France.

Frédéric Ebstein (F)

Nantes Université, CNRS, INSERM, l'institut du thorax, Nantes, France.

Classifications MeSH